The influence of interleukin-2 administration on met-enkephalins in patients with renal carcinoma.
Braczkowski
R
R
5th Dept. of Internal Medicine Silesian University School of Medicine, Bytom, Poland.
Huzarska
M
M
Zubelewicz
B
B
Romanowski
W
W
Cieśla
K
K
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002292:Carcinoma, Renal Cell / Q000097:blood / Q000628:therapy*; D004744:Enkephalin, Methionine / Q000097:blood*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay
D007376:Interleukin-2; D004744:Enkephalin, Methionine